drugset / Trial / NCT04354597
Hydroxychloroquine and Azithromycin as Prophylaxis for Healthcare Workers Dealing With COVID19 Patients
Withdrawn
King Hussein Cancer Center
RandomizedParallel-groupOpen-labelPrevention
Summary
The main objective of this study is to assess the efficacy of the combination hydroxychloroquine and Azithromycin (HCQ and AZ) in reducing the infection risk among health care professionals in direct contact with COVID-19 patients.
Timeline
- Start
- 2020-05-01
- Primary completion
- 2020-08-15
- Completion
- 2020-10-15
Outcome
Outcome not reported
Stopped: “New data not in favor of prophylaxis using this regimen”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azithromycin | Small molecule | 500 mg | Oral |
| Subject | Hydroxychloroquine | Small molecule | 400 mg | Oral |